Renal Cancer - Results from #5200

Profiling microRNA from nephrectomy and biopsy specimens: predictors of progression and survival in clear cell renal cell carcinoma April 24, 2017

Second Primary Cancer Risk Among Kidney Cancer Patients in Korea: A Population-Based Cohort Study April 24, 2017

Characterizing the outcomes of metastatic papillary renal cell carcinoma April 24, 2017

Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma April 24, 2017

Are We Using the Best Tumor Size Cut-Points for Renal Cell Carcinoma Staging? April 24, 2017

Predictive Nomogram for Recurrence Following Surgery for Non-Metastatic Renal Cell Cancer with Tumor Thrombus April 24, 2017

Prognostic impact of PD-1 and its ligands in renal cell carcinoma. April 24, 2017

Immune checkpoints and their inhibition in cancer and infectious diseases April 21, 2017

[Radical nephrectomy in a left pelvic dystopic kidney in a patient with renal cell carcinoma] April 21, 2017

Feasibility of Contrast-Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy April 21, 2017

Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy. April 21, 2017

Sunitinib Enables a Clinical and Pathological Complete Remission of Metastatic Renal Cell Carcinoma (mRCC). April 21, 2017

Recent advances in the management of renal cell carcinoma-a radiation oncology perspective April 20, 2017

Fate of newly developed pulmonary embolism after surgery for renal cell carcinoma with vena cava thrombus April 20, 2017

Hereditary leiomyomatosis and renal cell cancer (HLRCC): cutaneous and renal manifestations requiring a multidisciplinary team approach April 20, 2017

Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project) April 20, 2017

Maslinic Acid Inhibits Proliferation of Renal Cell Carcinoma Cell Lines and Suppresses Angiogenesis of Endothelial Cells. April 20, 2017

Predictive Factors for Second-Line Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Analysis. April 20, 2017

[Interdisciplinary Recommendations for the Treatment of Metastatic Renal Cell Carcinoma] April 19, 2017

Antiangiogenic therapy combined with immune checkpoint blockade in renal cancer. April 19, 2017

Page 261 of 456